Increased endocan expression as a biomarker of endothelial dysfunction in patients with metabolic syndrome

Pol Arch Intern Med. 2022 Aug 22;132(7-8):16292. doi: 10.20452/pamw.16292. Epub 2022 Jul 5.

Authors

Sylwia Iwańczyk¹, Anna Smukowska-Gorynia², Patrycja Woźniak², Marek Grygier², Maciej Lesiak², Aleksander Araszkiewicz²

Affiliations

¹ First Department of Cardiology, Poznan University of Medical Sciences, Poznań, Poland. syl.iwanczyk@gmail.com
² First Department of Cardiology, Poznan University of Medical Sciences, Poznań, Poland

PMID: 35785936
DOI: 10.20452/pamw.16292

No abstract available

MeSH terms

Biomarkers
Humans
Metabolic Syndrome*
Proteoglycans

Substances

Biomarkers
Proteoglycans